J. Safra Sarasin Holding’s Bristol-Myers Squibb BMY Stock Holding History

J. Safra Sarasin Holding’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$962K	Buy	16,418 +402	+3%	+$23.1K	0.01%	399
2026 Q1	$970K	Sell	16,016 -4,898	-23%	-$286K	0.02%	295
2025 Q4	$1.13M	Buy	+20,914	New	+$1.01M	0.02%	272
2025 Q3	–	Sell	-44,917	Closed	-$2.08M	–	484
2025 Q2	$2.08M	Buy	44,917 +22,927	+104%	+$1.13M	0.04%	212
2025 Q1	$1.34M	Buy	21,990 +3,457	+19%	+$202K	0.02%	278
2024 Q4	$1.05M	Sell	18,533 -17,940	-49%	-$1M	0.02%	316
2024 Q3	$1.89M	Sell	36,473 -821,199	-96%	-$38.5M	0.03%	217
2024 Q2	$35.6M	Buy	+857,672	New	+$38.4M	0.65%	46

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

J. Safra Sarasin Holding's BMY Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, buying an estimated $23.1K and bringing the position to 16,418 shares worth $962K. The position accounts for 0.01% of the portfolio, ranked #399.

J. Safra Sarasin Holding first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $35.6M in Q2 2024. 2,530 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

J. Safra Sarasin Holding held 16,418 shares of Bristol-Myers Squibb worth $962K as of Q2 2026.
J. Safra Sarasin Holding bought 402 Bristol-Myers Squibb shares in Q2 2026, an estimated $23.1K.
Bristol-Myers Squibb made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #399 holding.
J. Safra Sarasin Holding first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
J. Safra Sarasin Holding's Bristol-Myers Squibb position peaked at $35.6M in Q2 2024.
2,530 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.